{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:28:15Z","timestamp":1760909295566,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11102-022-01271-7","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T09:04:44Z","timestamp":1661331884000},"page":"687-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Special issue: Cushing's disease update"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"issue":"12","key":"1271_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1271_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01214-2","author":"H Raff","year":"2022","unstructured":"Raff H (2022) Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing\u2019s syndrome). Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01214-2","journal-title":"Pituitary"},{"key":"1271_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01249-5","author":"S Petersenn","year":"2022","unstructured":"Petersenn S (2022) Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol-accuracy and pitfalls when screening for Cushing\u2019s syndrome. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01249-5","journal-title":"Pituitary"},{"key":"1271_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01222-2","author":"C Scaroni","year":"2022","unstructured":"Scaroni C, Mondin A, Ceccato F (2022) How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing). Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01222-2","journal-title":"Pituitary"},{"key":"1271_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01241-z","author":"A Ferriere","year":"2022","unstructured":"Ferriere A, Tabarin A (2022) Biochemical testing to differentiate Cushing\u2019s disease from ectopic ACTH syndrome. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01241-z","journal-title":"Pituitary"},{"key":"1271_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01236-w","author":"WA Bashari","year":"2022","unstructured":"Bashari WA, Gillett D, MacFarlane J, Powlson AS, Kolias AG, Mannion R, Scoffings DJ, Mendichovszky IA, Jones J, Cheow HK, Koulouri O, Gurnell M (2022) Modern imaging in Cushing\u2019s disease. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01236-w","journal-title":"Pituitary"},{"key":"1271_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01254-8","author":"PS Jones","year":"2022","unstructured":"Jones PS, Swearingen B (2022) Pituitary surgery in Cushing\u2019s disease: first line treatment and role of reoperation. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01254-8","journal-title":"Pituitary"},{"key":"1271_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01226-y","author":"M Balomenaki","year":"2022","unstructured":"Balomenaki M, Vassiliadi DA, Tsagarakis S (2022) Cushing\u2019s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01226-y","journal-title":"Pituitary"},{"key":"1271_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01238-8","author":"MR Gadelha","year":"2022","unstructured":"Gadelha MR, Wildemberg LE, Shimon I (2022) Pituitary acting drugs: cabergoline and pasireotide. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01238-8","journal-title":"Pituitary"},{"key":"1271_CR10","doi-asserted-by":"crossref","unstructured":"Pivonello R, Simeoli C, DiPaola N, Colao A (2022) cushing\u2019s disease: adrenal steroidogenesis inhibitors. Pituitary (in press)","DOI":"10.1007\/s11102-022-01262-8"},{"key":"1271_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01227-x","author":"ME Molitch","year":"2022","unstructured":"Molitch ME (2022) Glucocorticoid receptor blockers. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01227-x","journal-title":"Pituitary"},{"key":"1271_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01244-w","author":"F Castinetti","year":"2022","unstructured":"Castinetti F (2022) Cushing\u2019s disease: role of preoperative and primary medical therapy. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01244-w","journal-title":"Pituitary"},{"key":"1271_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01234-y","author":"L Katznelson","year":"2022","unstructured":"Katznelson L (2022) Role of radiation in the treatment of Cushing disease. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01234-y","journal-title":"Pituitary"},{"key":"1271_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01260-w","author":"J Bertherat","year":"2022","unstructured":"Bertherat J (2022) Cushing\u2019s disease: role of bilateral adrenalectomy. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01260-w","journal-title":"Pituitary"},{"key":"1271_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01261-9","author":"RA Feelders","year":"2022","unstructured":"Feelders RA, Nieman LK (2022) Hypercoagulability in Cushing\u2019s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01261-9","journal-title":"Pituitary"},{"key":"1271_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01258-4","author":"A Coulden","year":"2022","unstructured":"Coulden A, Hamblin R, Wass J, Karavitaki N (2022) Cardiovascular health and mortality in Cushing\u2019s disease. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01258-4","journal-title":"Pituitary"},{"key":"1271_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01252-w","author":"S Frara","year":"2022","unstructured":"Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A (2022) Novel approaches to bone comorbidity in Cushing\u2019s disease: an update. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01252-w","journal-title":"Pituitary"},{"key":"1271_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01225-z","author":"CL Boguszewski","year":"2022","unstructured":"Boguszewski CL (2022) Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing\u2019s disease. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01225-z","journal-title":"Pituitary"},{"key":"1271_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01237-9","author":"CA Stratakis","year":"2022","unstructured":"Stratakis CA (2022) Cushing\u2019s disease in children: unique features and update on genetics. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01237-9","journal-title":"Pituitary"},{"key":"1271_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01245-9","author":"SM Webb","year":"2022","unstructured":"Webb SM, Valassi E (2022) Quality of life impairment after a diagnosis of Cushing\u2019s syndrome. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01245-9","journal-title":"Pituitary"},{"key":"1271_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01253-9","author":"M Theodoropoulou","year":"2022","unstructured":"Theodoropoulou M, Reincke M (2022) Genetics of Cushing\u2019s disease: from the lab to clinical practice. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01253-9","journal-title":"Pituitary"},{"key":"1271_CR22","doi-asserted-by":"crossref","unstructured":"Couselo M, Frara S, Giustina A, Casanueva F (2022) Pituitary tumor centers of excellence. Pituitary (in press)","DOI":"10.1007\/s11102-022-01264-6"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01271-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T09:25:20Z","timestamp":1666430720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01271-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01271-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"3 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MF reports serving as an investigator with research grants to Oregon Health and Science University from Recordati, and Xeris (Strongbridge Biopharma); has received occasional scientific consulting honoraria from HRA Pharma, Recordati, Sparrow Pharmaceuticals, and Xeris (Strongbridge Biopharma); MF was co-chair of the Pituitary Society Cushing's consensus meeting and is a member of the editorial board for Pituitary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}